VENTIRX PHARMACEUTICALS
VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of medicines for the treatment of cancer, and respiratory and autoimmune diseases. The company focuses on the development of small molecule product candidates targeting toll-like receptor 8 (TLR8) agonists and antagonists. Its product pipeline comprises VTX-2337, a small molecule TLR8 agonist that stimulates myeloid dendritic cells and monocytes, and enhances natural killer... cell responses for the treatment of solid tumors, ovarian and breast cancers, and NHL and SCHN; VTX-1463, a stand alone agent for the treatment of seasonal and perennial allergies; TLR8 antagonists for the treatment of autoimmune diseases; and multiple compounds that are treated as vaccine adjuvants. The company has a strategic agreement/collaboration with Celgene Corporation. VentiRx Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Seattle, Washington with operations in San Diego.
VENTIRX PHARMACEUTICALS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2006-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.ventirx.com
Total Employee:
11+
Status:
Active
Contact:
(206) 689-2259
Email Addresses:
[email protected]
Total Funding:
104.5 M USD
Technology used in webpage:
GStatic Google Static Content Proofpoint CSC Global DNS CSC
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series B - VentiRx Pharmaceuticals
MedImmune Ventures
MedImmune Ventures investment in Series B - VentiRx Pharmaceuticals
Celgene
Celgene investment in Series B - VentiRx Pharmaceuticals
ARCH Venture Partners
ARCH Venture Partners investment in Series B - VentiRx Pharmaceuticals
Domain Associates
Domain Associates investment in Series B - VentiRx Pharmaceuticals
Domain Associates
Domain Associates investment in Series A - VentiRx Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - VentiRx Pharmaceuticals
ARCH Venture Partners
ARCH Venture Partners investment in Series A - VentiRx Pharmaceuticals
MedImmune Ventures
MedImmune Ventures investment in Series A - VentiRx Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - VentiRx Pharmaceuticals
Official Site Inspections
http://www.ventirx.com
- Host name: 165.160.15.20
- IP address: 165.160.15.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "VentiRx Pharmaceuticals"
VentiRx Pharmaceuticals - Crunchbase Company Profile
VentiRx Pharmaceuticals develops novel TLR8 therapeutics for the treatment of cancer, allergy, and respiratory and autoimmune diseases. View contacts for VentiRx Pharmaceuticals to …See details»
Organization | VentiRx Pharmaceuticals Inc.
VentiRx Pharmaceuticals Inc. Report issue For profit Phase 1 Phase 2 Founded: Seattle WA United States (2006)See details»
VentiRx Pharmaceuticals - VentureRadar
Jan 2, 2017 · VentiRx is a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like Receptor 8 (TLR8) immunotherapies for …See details»
VentiRx Pharmaceuticals - PitchBook
VentiRx Pharmaceuticals is headquartered in Seattle, WA. What is the size of VentiRx Pharmaceuticals? VentiRx Pharmaceuticals has 19 total employees. What industry is VentiRx …See details»
VentiRx Pharmaceuticals - Contacts, Employees, Board …
VentiRx Pharmaceuticals has 6 board members and advisors, including Nicole Vitullo. VentiRx Pharmaceuticals develops novel TLR8 therapeutics for the treatment of cancer, allergy, and …See details»
VentiRx Pharmaceuticals Announces Exclusive, Strategic …
Oct 4, 2012 · VentiRx Pharmaceuticals Inc. is a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) …See details»
VentiRx Pharmaceuticals - Craft
VentiRx Pharmaceuticals is a clinical stage biopharmaceutical company, engages in the development and commercialization of medicines for the treatment of cancer, and respiratory …See details»
Chairman & CEO at VentiRx Pharmaceuticals
Giovanni Caforio, MD, has been the chief executive officer of Bristol Myers Squibb since May 2015 and has been serving on the company’s Board of Directors since June 2014. In May 2017, he assumed the role of chairman of …See details»
VentiRx Pharmaceuticals - Funding, Financials, Valuation …
VentiRx Pharmaceuticals develops novel TLR8 therapeutics for the treatment of cancer, allergy, and respiratory and autoimmune diseases.See details»
VentiRx Pharmaceuticals' Novel TLR8 Agonist, VTX-2337, …
Oct 4, 2010 · VentiRx Pharmaceuticals, Inc. is a biopharmaceutical company committed to the development and commercialization of novel medicines for the treatment of cancer, respiratory …See details»
VentiRx Pharmaceuticals Commences Phase I Clinical …
SAN DIEGO, Dec. 4 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) agonists for the …See details»
VentiRx Pharmaceuticals Announces Fast Track …
Sep 2, 2014 · VentiRx is a privately held organization based in Seattle, Washington. For additional information, please visit www.ventirx.com. Contact: Katie Fanning Chief Operating Officer …See details»
VentiRx Pharmaceuticals Reports Positive Clinical Data for …
Oct 7, 2010 · VentiRx is a privately held organization with operations in San Diego and Seattle. For additional information, please visit www.ventirx.com. SOURCE VentiRx Pharmaceuticals, Inc.See details»
Ludwig Cancer Research
Sep 3, 2014 · VentiRx Pharmaceuticals Inc. is a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) …See details»
Adam Lenkowsky - EVP & Chief Commercialization Officer …
Adam Lenkowsky is executive vice president, chief commercialization officer (CCO) at Bristol Myers Squibb. In this role, Adam leads the worldwide Commercial and Medical organizations …See details»
VentiRx Pharmaceuticals Raises $25 Million in Series A …
Jan 12, 2010 · VentiRx is a privately held organization headquartered in San Diego with operations in Seattle. For additional information, please visit www.ventirx.com. About …See details»
VentiRx Pharmaceuticals Presents Results from Phase 1 …
Jun 6, 2011 · VentiRx Pharmaceuticals Inc. is a biopharmaceutical company committed to the development and commercialization of novel medicines for the treatment of cancer, respiratory …See details»
VentiRx Pharmaceuticals Announces the Completion of …
Apr 17, 2014 · /PRNewswire/ -- VentiRx Pharmaceuticals, Inc. today announced that enrollment has been completed in GOG-3003 (NCT01666444), a randomized, placebo-controlled...See details»
homepage - Ventrex
R&D project house, prototype-manufacturing and test bench under a single roof. From R&D concepts to high-quality product samples. In-house, self-designed testing equipment with …See details»